Tumor suppressor Nf2/merlin drives Schwann cell changes following electromagnetic field exposure through Hippo-dependent mechanisms

被引：21

作者：

Colciago, A. ^{[1
]}

Melfi, S. ^{[1
]}

Giannotti, G. ^{[1
]}

Bonalume, V ^{[1
]}

Ballabio, M. ^{[1
]}

Caffino, L. ^{[1
]}

Fumagalli, F. ^{[1
]}

Magnaghi, V ^{[1
]}

机构：

[1] Univ Milan, Dipartimento Sci Farmacol & Biomol, Via G Balzaretti 9, I-20133 Milan, Italy

来源：

CELL DEATH DISCOVERY | 2015年 / 1卷

关键词：

D O I：

10.1038/cddiscovery.2015.21

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Previous evidence showed mutations of the neurofibromin type 2 gene (Nf2), encoding the tumor suppressor protein merlin, in sporadic and vestibular schwannomas affecting Schwann cells (SCs). Accordingly, efforts have been addressed to identify possible factors, even environmental, that may regulate neurofibromas growth. In this context, we investigated the exposure of SC to an electromagnetic field (EMF), which is an environmental issue modulating biological processes. Here, we show that SC exposed to 50 Hz EMFs changes their morphology, proliferation, migration and myelinating capability. In these cells, merlin is downregulated, leading to activation of two intracellular signaling pathways, ERK/AKT and Hippo. Interestingly, SC changes their phenotype toward a proliferative/migrating state, which in principle may be pathologically relevant for schwannoma development.

引用

页数：10

共 41 条

[1] Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis [J].

Basu, S ;

Totty, NF ;

Irwin, MS ;

Sudol, M ;

Downward, J .

MOLECULAR CELL, 2003, 11 (01) :11-23

[2] Acoustic neuroma risk in relation to mobile telephone use: Results of the INTERPHONE international case-control study [J].

Cardis, E. ;

Deltour, I. ;

Vrijheid, M. ;

Evrard, A. S. ;

Moissonnier, M. ;

Armstrong, B. ;

Brown, J. ;

Giles, G. ;

Siemiatycki, J. ;

Nadon, L. ;

Parent, M. E. ;

Krewski, D. ;

McBride, M. M. ;

Johansen, C. ;

Christensen, H. C. ;

Auvinen, A. ;

Kurttio, P. ;

Lahkola, A. ;

Salminen, T. ;

Hours, M. ;

Bernard, M. ;

Montestruq, L. ;

Schuez, J. ;

Blettner, M. ;

Berg-Beckhoff, G. ;

Schlehofer, B. ;

Sadetzki, S. ;

Chetrit, A. ;

Jarus-Hakak, A. ;

Lagorio, S. ;

Iavarone, I. ;

Takebayashi, T. ;

Yamaguchi, N. ;

Woodward, A. ;

Cook, A. ;

Pearce, N. ;

Tynes, T. ;

Klaeboe, L. ;

Blaasaas, K. G. ;

Feychting, M. ;

Lonn, S. ;

Ahlbom, A. ;

McKinney, P. A. ;

Hepworth, S. J. ;

Muir, K. R. ;

Swerdlow, A. J. ;

Schoemaker, M. J. .

CANCER EPIDEMIOLOGY, 2011, 35 (05) :453-464

[3]

Carpenter David O., 2013, Reviews on Environmental Health, V28, P159, DOI 10.1515/reveh-2013-0016

[4] Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms [J].

Carroll, Steven L. .

ACTA NEUROPATHOLOGICA, 2012, 123 (03) :321-348

[5] ACIDIC FIBROBLAST GROWTH-FACTOR STIMULATES ADRENAL CHROMAFFIN CELLS TO PROLIFERATE AND TO EXTEND NEURITES, BUT IS NOT A LONG-TERM SURVIVAL FACTOR [J].

CLAUDE, P ;

PARADA, IM ;

GORDON, KA ;

DAMORE, PA ;

WAGNER, JA .

NEURON, 1988, 1 (09) :783-790

[6] A molecular mechanotransduction pathway regulates collective migration of epithelial cells [J].

Das, Tamal ;

Safferling, Kai ;

Rausch, Sebastian ;

Grabe, Niels ;

Boehm, Heike ;

Spatz, Joachim P. .

NATURE CELL BIOLOGY, 2015, 17 (03) :276-+

[7] Neurofibromatosis type 2 (NF2): A clinical and molecular review [J].

Evans, D. Gareth R. .

ORPHANET JOURNAL OF RARE DISEASES, 2009, 4

[8] Effects of electromagnetic fields on cells: Physiological and therapeutical approaches and molecular mechanisms of interaction [J].

Funk, Richard H. W. ;

Monsees, Thomas K. .

CELLS TISSUES ORGANS, 2006, 182 (02) :59-78

[9] Increased DNA oxidation (8-0HdG) and protein oxidation (AOPP) by low level electromagnetic field (2.45 GHz) in rat brain and protective effect of garlic [J].

Gurler, Hatice S. ;

Bilgici, Birsen ;

Akar, Aysegul K. ;

Tomak, Leman ;

Bedir, Abdulkerim .

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2014, 90 (10) :892-896

[10] Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas [J].

Hadfield, K. D. ;

Smith, M. J. ;

Urquhart, J. E. ;

Wallace, A. J. ;

Bowers, N. L. ;

King, A. T. ;

Rutherford, S. A. ;

Trump, D. ;

Newman, W. G. ;

Evans, D. G. .

ONCOGENE, 2010, 29 (47) :6216-6221

← 1 2 3 4 5 →